MY REWARDS INTERNATIONAL LIMITED (MRI)

The company has entered into a Heads of Agreement to acquire Fly Wallet Pty Ltd, securing My Rewards' position to create a Global Rewards & loyalty program. The acquisition is conditional on regulatory and ASX approvals and an independent valuation of Fly Wallet. The consideration payable is $2 million in cash and MRI shares, with no change to MRI's Board of Directors.

The company lodges its application for quotation of securities.

The company lodges its preliminary final report.

The company releases the results of its meeting.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

Notice is given that the Meeting will be held at: 10:00 am (Melbourne time) on Tuesday 27 August 2024. It's a Virtual Meeting through https://web.lumiagm.com/369700412.

The company releases a notice of application for quotation of securities.

The company releases a notice of proposed issue of securities.

The Company has finalised the Side Deed with iGoDirect Group to facilitate completion occurring under the Asset Sale Agreement. As at the date of this announcement, 19 out of 20 Key Customer Contracts have been successfully assigned resulting in a further reduction of the loan by $76,477.66. The last outstanding Key Customer Contract was declined by the customer to be assigned. iGoDirect has agreed for MRI to find a substitute customer and effectively assign the contract for a similar value as the Unassigned Contract on or before 12th September 2024 to further reduce the loan by $11,580.47

$1million funding committed to be drawn down in tranches. Issue Price - $0.009. Shares under the placement to be issued to Abreco Enterprises Pty Ltd (Abreco). Funds to be applied towards working capital for the Company.

The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

My Rewards International Limited and iGoDirect Group Pty Ltd have agreed to extend the Post Completion Subsequent End Date from today (28th June 2024) to Friday 11 July 2024 to deliver remaining outstanding requirements under the Side Deed entered into by both parties on 14 May 2024.

The company responds to the query of asx-general-aware, referring to the letter dated 13th May 2024, providing a response to each of the questions.

The company has signed a Side Deed with iGoDirect Group Pty Ltd to facilitate completion under the Asset Sale Agreement. The company and iGoDirect have been discussing how to handle a few of the 20 client employee/member benefits agreements that require additional time to obtain consents. The Side Deed confirms completion on or around 14 May 2024, with 17 out of 20 Key Customer Contracts acknowledged and confirmed. An additional 45 days are provided from the Completion Date to procure the assignment of the remaining 3 Key Customer Contracts and attend to other conditions subsequent. The company is confident that it will be able to obtain the assignment of the remaining 3 Key Customer Contracts by the Condition Subsequent End Date, resulting in no material change to the Asset Sale Agreement. The balance of the loan principal of $401,500 plus interest owing under the Loan Facility Agreement is due on 14 September 2024.

The company has been restricted the Australian Securities and Investments Corporation from using transaction-specific disclosure exceptions under s713(6) of the Corporations Act 2001(Cth) until May 2, 2025. This means MRI cannot rely on reduced disclosure rules under s713 and must issue a full prospectus to raise funds from certain investors, without affecting MRI's operations and business.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company issues a response to ASX Aware Query.

The Company has entered into a suite of agreements with iGoDirect Group Pty Ltd and/or its nominee which will see the Company reduce its loan facility from iGoDirect by $725,000.00.

The Company and iGoDirect Group has agreed to extend the due date of the loan to the 9th of April 2024. Further to the announcement dated 8th April 2024, MRI is finalising discussions with iGoDirect in relation to the loan and expects to provide a formal update by 9th April 2024.

My Rewards International Limited wishes to provide a further update on the iGoDirect Group Pty Ltd $1 million loan as announced on 20th November 2023. The Company and iGoDirect Group has agreed to extend the due date of the loan to the 8th of April 2024. MRI is continuing discussions with iGoDirect in relation to the loan and expects to provide a formal update by 8th April 2024.

The Company and iGoDirect Group has agreed to extend the due date of the loan to the 5th of April 2024. MRI is currently in ongoing discussions with iGoDirect in relation to the loan and expects to provide a formal update by 5th April 2024.

The Company and iGoDirect Group has agreed to extend the due date of the loan to the 5th of April 2024. MRI is currently in ongoing discussions with iGoDirect in relation to the loan and expects to provide a formal update by 5th April 2024.

The company releases a notice of application for quotation of securities

The directors of MRI have re-opened the FY 2023 annual accounts in order for the auditors, RSM, to review requested additional information and supporting documentation. The company is in the final stages of compiling the information and expects to provide RSM with the information by 15 March 2024. RSM will then proceed to review the information and work towards providing an updated audited set of accounts for the FY2023. The reason the directors have re-opened the accounts and following the above process is to seek an audit opinion for FY 2023 annual accounts. The Half-year 31 December 2023 will be finalised after the FY2023 Annual Report has been re-lodged with the ASX and ASIC. Until the FY 2023 annual accounts are finalised, the company is not in a position to finalise a set of accounts for the Interim financial report for the half-year 31 December 2023 as the opening balances for the period may be impacted based on the view of the auditors for FY 2023 annual accounts.

The company releases a notice of application for quotation of securities.

28,707,000 fully paid ordinary shares will be released from escrow on 15 February 2024. An Appendix 2A will be lodged with the ASX to request the quotation of these shares

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company releases the results of its Annual General Meeting.

The company releases a Company Presentation.

The company releases the Chairman's Address to Shareholders.

The company issues a response to Third ASX Aware Letter.

The company's AGM will be held at 10:00 am (Melbourne time) on Wednesday 20 December 2023 online at https://web.lumiagm.com/373634963.

The Company has entered into a A$1 million loan agreement with iGoDirect Group Pty Ltd which will support the Company for the medium term.

The company issues a response to further ASX Query Letter.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The securities of My Rewards International Limited were suspended from quotation on 2 October 2023 under Listing Rule 17.3. MRI's Annual Report for the financial year ended 30 June 2023 contained a disclaimer of opinion by MRI's auditors in respect of MRI's financial report and remuneration report. ASX determined that MRI's financial condition was not adequate to warrant the continued quotation of its securities and therefore not in compliance with Listing Rule 12.2. On 16 October 2023, ASX required MRI to provide responses to ASX's initial queries relating to MRI's Annual Report for release to the market which are set out in the announcement entitled "˜Response to ASX Query Letter' dated 27 October 2023 and lodged on the ASX Market Announcements Platform today, 30 October 2023. Until such time as MRI rectifies to ASX's satisfaction the disclaimed audit opinions contained in its Annual Report and ASX is otherwise satisfied MRI is in compliance with the ASX Listing Rules, including Listing Rule 12.2, MRI's securities will continue to be suspended from quotation pursuant to Listing Rule 17.3.

The company issues a response to ASX Query Letter.

The securities of My Rewards International Limited will be suspended from quotation immediately in accordance with Listing Rule 17.3. ASX has determined that MRI's financial condition is not adequate to warrant the continued quotation of its securities and therefore is in breach of Listing Rule 12.2. The suspension will continue until MRI is able to demonstrate compliance with Listing Rule 12.2.

listed entity carried for record purposes only